Supplementary Data from Senescent Stromal Cells Promote Cancer Resistance Through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles

Han Liu,Qilai Long,Shenjun Li,Qixia Xu,Boyi Zhang,Xuefeng Dou,Min Qian,Yannasittha Jiramongkol,Jianming Guo,Lei Cao,Y. Eugene Chin,Eric W.‐F. Lam,Jin Jiang,Yu Sun

DOI: https://doi.org/10.1158/0008-5472.22425768.v1

2023-01-01

Abstract:Primer information summary.

What problem does this paper attempt to address?

Supplementary Data from Senescent Stromal Cells Promote Cancer Resistance Through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles

Han Liu,Qilai Long,Shenjun Li,Qixia Xu,Boyi Zhang,Xuefeng Dou,Min Qian,Yannasittha Jiramongkol,Jianming Guo,Lei Cao,Y. Eugene Chin,Eric W.‐F. Lam,Jin Jiang,Yu Sun

DOI: https://doi.org/10.1158/0008-5472.22425768

2023-01-01

Abstract:Primer information summary.
Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Wenqun Zhong,Zhang Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23952936.v1

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Abstract 2969: Senescent Stromal Cells Promote Cancer Resistance Via Sirt1 Loss-Potentiated Biogenesis of Small Extracellular Vesicles

Liu Han,Qilai Long,Eric Lam,Yu Sun

DOI: https://doi.org/10.1158/1538-7445.am2020-2969

IF: 11.2

2020-01-01

Cancer Research

Abstract:Abstract Cellular senescence is a potent tumor-suppressive program that prevents neoplastic events. Paradoxically, senescent cells develop an inflammatory secretome, termed the senescence-associated secretory phenotype (SASP) and implicated in age-related pathologies including cancer. Here we report that senescent cells actively synthesize and release small extracellular vesicles (sEVs) with a distinctive size distribution. Mechanistically, SIRT1 loss supports accelerated sEV production despite enhanced proteome-wide ubiquitination, a process correlated with ATP6V1A downregulation and defective lysosomal acidification. Senescent stromal cell-derived sEVs carry a special set of cargoes, including small RNA species such as microRNAs (miRNAs) whose spectrum markedly differ from that of proliferating cell-secreted sEVs. Once released, senescent stromal sEVs significantly alter the expression profile of recipient cancer cells and enhance their aggressiveness, specifically drug resistance mediated by expression of ATP binding cassette subfamily B member 4 (ABCB4). Targeting SIRT1 with an agonist SRT2104 prevents development of cancer resistance through restraining sEV production by senescent stromal cells. In clinical oncology, sEVs in peripheral blood of posttreatment cancer patients are readily detectable by routine biotechniques, presenting a novel biomarker to monitor therapeutic efficacy and predict long term outcome. Together, our study identifies a distinct mechanism supporting pathological activities of senescent cells, and provides a novel avenue to circumvent advanced human malignancies by co-targeting cancer cells and their surrounding microenvironment, which contributes to drug resistance via secretion of sEVs from senescent stromal cells. Citation Format: Liu Han, Qilai Long, Eric Lam, Yu Sun. Senescent stromal cells promote cancer resistance via Sirt1 loss-potentiated biogenesis of small extracellular vesicles [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 2969.
Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo,Hao Wang,Jiahao Duan,Wenwu Luo,Rongrong Zhao,Yuting Shen,Bijun Wang,Siqi Tao,Yi Sun,Qian Ye,Xiaomin Bi,Hui Yuan,Qiang Wu,Peter E. Lobie,Tao Zhu,Sheng Tan,Xing Huang,Zhengsheng Wu

DOI: https://doi.org/10.1158/0008-5472.22432764.v1

2023-01-01

Abstract:Supplementary Data from An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Sen Ye,Yan-Fu Ding,Wen-Huan Jia,Xiao-Li Liu,Jing-Yi Feng,Qian Zhu,Sun-Li Cai,Yao-Shun Yang,Qian-Yun Lu,Xue-Ting Huang,Jin-Shu Yang,Sheng-Nan Jia,Guo-Ping Ding,Yue-Hong Wang,Jiao-Jiao Zhou,Yi-Ding Chen,Wei-Jun Yang

DOI: https://doi.org/10.1158/0008-5472.22422729

2023-01-01

Abstract:Supplementary Table S1 and Supplementary Figure S1 to S11
Targeted Clearance of Senescent Cells via Engineered Extracellular Vesicles Reprograms Tumor Immunosuppressive Microenvironment

Panpan Ji,Chen Wang,Yang Liu,Xin Guo,Yuan Liang,Jiangpeng Wei,Zhaoyou Liu,Li Gong,Guodong Yang,Gang Ji

DOI: https://doi.org/10.1002/adhm.202400945

IF: 10

2024-05-26

Advanced Healthcare Materials

Abstract:Unravelling the mechanisms for the immunosuppressive tumor microenvironment and developing corresponding therapeutic strategies are of great importance to improve the cancer immunotherapy. In this study, we have revealed that there are abundant senescent cells accumulated in the colon cancer tissue, which contributes greatly to the immunosuppressive microenvironment. Oral delivery of Dasatinib and Quercetin (D+Q) eliminates the senescent cells with compromised efficiency due to the poor tumor penetration and short half‐life. To improve the efficacy of senescent cell clearance, we have developed an extracellular vesicle (EV)‐based senolytic strategy. The engineered senolytic EVs have anti‐GPNMB (a senescent cell surface marker) displayed on the surface and D+Q loaded on the membrane. In a syngeneic mouse model, senolytic EVs efficiently and selectively eradicate the senescent cells and in turn unleashes the antitumor immunity. With the antitumor immunity boosted, cancer growth is inhibited and the survival is prolonged. In summary, we here have illuminated that senescent cells contribute to the immunosuppressive microenvironment in colon cancer and proposed a novel strategy to conquer the problem by EV‐based senolytics. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Extracellular vesicles within a tumourigenic therapy-induced senescent tumour secretome are able to confer anti-cancer properties

Matius Robert,Rekha Jakhar,Karen Carmelina Crasta

DOI: https://doi.org/10.1101/2024.03.29.586905

2024-03-29

Abstract:Cellular senescence is a fundamental response against chemotherapy to avoid cell death, and the resulting therapy-induced senescent (TIS) cells have been associated with cancer recurrence and therapy resistance via its paracrine activity. The paracrine activity of TIS cells is heavily influenced by the composition and dynamics of the senescence associated secretory phenotype (SASP). The SASP itself is known to be predominantly composed by soluble cytokines, chemokines, and growth factors. The non-soluble fraction of SASP, specifically small extracellular vesicles (sEVs), represents an underappreciated component of SASP and are still poorly characterized. Here we show that the SASP may mediate tumor recurrence and distant metastasis in mice, as well as support invasive and migratory behavior . Remarkably, while the SASP itself may be pro-tumorigenic, we found that therapy-induced senescent sEVs isolated from the SASP are able to reduce syngeneic tumor growth . Transcriptomic analysis from therapy-induced sEV recipient mice tissue revealed downregulation of proliferation and mitotic pathways, akin to a senescence-like phenotype, along with upregulation of inflammatory and antigen-presentation pathways. Further characterization revealed that TIS sEVs recipient cells are less invasive and migratory, and that they also exhibit elevated level of reactive oxygen species (ROS), concomitantly with sustained γ-H2AX expression and micronuclei generation. Our results indicate that therapy-induced senescent cancer cell-derived sEVs should be considered as distinct SASP entities.

Cancer Biology
Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression

Qixia Xu,Qilai Long,Dexiang Zhu,Da Fu,Boyi Zhang,Liu Han,Min Qian,Jianming Guo,Jianmin Xu,Liu Cao,Y. Eugene Chin,Jean‐Philippe Coppé,Eric W.‐F. Lam,Judith Campisi,Yu Sun

DOI: https://doi.org/10.1111/acel.13027

IF: 11.005

2019-09-07

Aging Cell

Abstract:<p>Aging is characterized by a progressive loss of physiological integrity, while cancer represents one of the primary pathological factors that severely threaten human lifespan and healthspan. In clinical oncology, drug resistance limits the efficacy of most anticancer treatments, and identification of major mechanisms remains a key to solve this challenging issue. Here, we highlight the multifaceted senescence‐associated secretory phenotype (SASP), which comprises numerous soluble factors including amphiregulin (AREG). Production of AREG is triggered by DNA damage to stromal cells, which passively enter senescence in the tumor microenvironment (TME), a process that remarkably enhances cancer malignancy including acquired resistance mediated by EGFR. Furthermore, paracrine AREG induces programmed cell death 1 ligand (PD‐L1) expression in recipient cancer cells and creates an immunosuppressive TME via immune checkpoint activation against cytotoxic lymphocytes. Targeting AREG not only minimized chemoresistance of cancer cells, but also restored immunocompetency when combined with classical chemotherapy in humanized animals. Our study underscores the potential of in vivo SASP in driving the TME‐mediated drug resistance and shaping an immunosuppressive niche, and provides the proof of principle of targeting major SASP factors to improve therapeutic outcome in cancer medicine, the success of which can substantially reduce aging‐related morbidity and mortality.</p>

cell biology,geriatrics & gerontology
Abstract P46: Small Extracellular Vesicles from Therapy-induced Senescent TNBC Elicit Paracrine Anti-tumour Effects

Matius Robert,Rekha Jakhar,Bijin Veonice Au,Gracie Wee Ling Eng,Alvin Kunyao Gao,You Heng Chuah,Karishma Sachaphibulkij,Lina Hsiu Kim Lim,Derrick Sek Tong Ong,Elaine Hsuen Lim,Yoko Itahana,Koji Itahana,Jit Kong Cheong,John Edward Connolly,Karen Carmelina Crasta

DOI: https://doi.org/10.1158/1538-7445.fcs2023-p46

IF: 11.2

2024-04-16

Cancer Research

Abstract:Triple-negative breast cancers (TNBC), associated with poor prognosis and high tumour recurrence, are often treated with taxanes. However, cells may bypass treatment-induced cell death via mitotic slippage, resulting in multinucleated polyploid cells and therapy-induced senescence (TIS). TIS cancer cells represent a population of residual disease and may modulate therapy resistance and recurrence through secretion of the senescence-associated secretory phenotype (SASP). While SASP have been heavily linked with pro-tumorigenic behaviour mediated through soluble cytokines, small extracellular vesicles (sEVs) derived from TIS cancer cells represent an underappreciated aspect of the senescent tumour secretome, as its mechanistic role in mediating paracrine effects remains poorly understood. In this study, we uncovered an unexpected role for TIS-derived sEVs within the secretome, which conferred paracrine anti-tumour activity in recipient TNBC cancer cells, in contrast to SASP that support pro-tumorigenic behaviour. SEVs profiling through mass-spectrometry revealed that DKK1, a negative regulator of WNT signalling, is enriched in TIS-derived sEVs. Further investigation into the tumour microenvironment with animal models and neoadjuvant chemo-treated patient samples revealed STING-dependent immune response. Hence, our study suggests that sEVs should be considered as distinct SASP entities within the senescent tumour secretome and provide an additional basis for combinatorial use of senomorphics with taxanes to potentially modulate senescence-associated sEVs while suppressing pro-tumorigenic SASP factors. Citation Format: Matius Robert, Rekha Jakhar, Bijin Veonice Au, Gracie Wee Ling Eng, Alvin Kunyao Gao, You Heng Chuah, Karishma Sachaphibulkij, Lina Hsiu Kim Lim, Derrick Sek Tong Ong, Elaine Hsuen Lim, Yoko Itahana, Koji Itahana, Jit Kong Cheong, John Edward Connolly, Karen Carmelina Crasta. Small Extracellular Vesicles from Therapy-induced Senescent TNBC Elicit Paracrine Anti-tumour Effects [abstract]. In: Proceedings of Frontiers in Cancer Science; 2023 Nov 6-8; Singapore. Philadelphia (PA): AACR; Cancer Res 2024;84(8_Suppl) nr P46.

oncology
Supplementary Data from Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor–Stroma Cross-talk

Hui Wang,Huibi Xu,Wei Chen,Ming Cheng,Li Zou,Yang Qin,Chi Bun Chan,Huiping Zhu,Ceshi Chen,Jian‐Yun Nie,Baowei Jiao

DOI: https://doi.org/10.1158/0008-5472.22431015

2023-01-01

Abstract:Supplementary Data from Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor–Stroma Cross-talk
Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation

Dan Zhang,Jian-Wei Zhang,Hui Xu,Xin Chen,Yu Gao,Huan-Gang Jiang,You Wang,Han Wu,Lei Yang,Wen-Bo Wang,Jing Dai,Ling Xia,Jin Peng,Fu-Xiang Zhou

DOI: https://doi.org/10.1186/s12943-024-01985-1

IF: 37.3

2024-04-06

Molecular Cancer

Abstract:Cellular senescence frequently occurs during anti-cancer treatment, and persistent senescent tumor cells (STCs) unfavorably promote tumor progression through paracrine secretion of the senescence-associated secretory phenotype (SASP). Extracellular vesicles (EVs) have recently emerged as a novel component of the SASP and primarily mediate the tumor-promoting effect of the SASP. Of note, the potential effect of EVs released from STCs on tumor progression remains largely unknown.

oncology,biochemistry & molecular biology
Small Extracellular Vesicles Maintain Homeostasis of Senescent Mesenchymal Stem Cells at Least Through Excreting Harmful Lipids

Liping Wang,Huan Zhang,Xian Xiao,Shihua Wang,Robert Chunhua Zhao

DOI: https://doi.org/10.1089/scd.2023.0079

Abstract:Mesenchymal stem cells (MSCs) play an essential role in multiple physiological processes in vivo and a promising cell-based therapy for various diseases. Nonetheless, MSCs suffer from senescence with expansion culture, leading to a limitation for their clinical application. Recently, it was reported that small extracellular vesicles (sEVs) are involved in regulation of senescence in tumor cells and fibroblasts. However, the biological roles of sEVs in senescent MSCs (Sen MSCs) are poorly understood. In this study, we established a replicative senescence model of MSCs by successive passages and compared the phenotypic changes between presenescent MSCs (Pre-Sen MSCs) and Sen MSCs and found that Sen MSCs exhibited a diminished adipogenic and osteogenic differentiation potential and elevated senescence-associated secretory phenotype levels. In addition, we found that sEV secretion was increased in Sen MSCs, and inhibition of sEV secretion led to apoptosis, DNA damage, and decreased cell viability, suggesting that increased sEV secretion plays an important role in maintaining Sen MSC homeostasis. To further investigate the molecular mechanisms, metabolomic profiling of Pre-Sen MSC-derived sEVs (Pre-Sen-sEVs) and Sen MSC-derived sEVs (Sen-sEVs) was performed. The results showed that lipid metabolites were significantly increased in Sen-sEVs and these significantly upregulated lipid metabolites were shown to be toxic for inducing cellular senescence and apoptosis in previous studies. Kyoto Encyclopedia of Genes and Genomes analysis revealed enrichment of differential metabolites between Pre-Sen-sEVs and Sen-sEVs mainly in 25 signaling pathways, of which 21 metabolic pathways have been shown to be closely associated with senescence. Taken together, our findings suggested that increased sEV secretion maintains Sen MSC homeostasis, at least in part, by excreting harmful lipids, thus providing new insights into the regulation of senescence by sEVs.
Supplementary Data from Suppression of Anoikis by <i>skp2</i> Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Xiao-Chun Wang,Yu-Peng Wu,Bo Ye,De-Chen Lin,Yan-Bin Feng,Zi-Qiang Zhang,Xin Xu,Ya-Ling Han,Yan Cai,Jin-Tang Dong,Qi-Min Zhan,Min Wu,Ming-Rong Wang

DOI: https://doi.org/10.1158/1541-7786.22518823

2023-01-01

Abstract:Supplementary Data from Suppression of Anoikis by SKP2 Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma
Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Tianyuan Liu,Xuan Zhao,Yuan Lin,Qi Luo,Shaosen Zhang,Yiyi Xi,Yamei Chen,Lin,Wenyi Fan,Jie Yang,Yuling Ma,Alok K. Maity,Yanyi Huang,Jianbin Wang,Jiang Chang,Dongxin Lin,Andrew E. Teschendorff,Chen Wu

DOI: https://doi.org/10.1158/0008-5472.22431860.v1

2023-01-01

Abstract:Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression
Senescent cell-derived extracellular vesicles inhibit cancer recurrence by coordinating immune surveillance

Tahereh Ziglari,Nicholas Calistri,Jennifer M Finan,Daniel Derrick,Ernesto S Nakayasu,Meagan Burnet,Jennifer E Kyle,Matthew W Hoare,Laura Heiser,Ferdinando Pucci

DOI: https://doi.org/10.1101/2022.06.30.498366

2024-08-28

Abstract:Extracellular vesicles (EVs) are key signaling mediators. To explore the role of senescent cell-derived extracellular vesicles (senEVs) in inflammatory responses to senescence, we developed an engraftment-based senescence model in wild-type mice and genetically blocked senEV release in vivo, without significantly affecting soluble mediators. Our results demonstrate that senEVs are both necessary and sufficient to trigger immune-mediated clearance of senescent cells, thereby suppressing tumor growth. In the absence of senEVs, the recruitment of MHC-II+ antigen presenting cells to the senescence microenvironment was markedly impaired. Blocking senEV release redirected the primary target of senescent cell signaling from antigen presenting cells to neutrophils. Through comprehensive transcriptional and proteomic analyses, we identified six ligands specific to senEVs, highlighting their role in promoting antigen presenting cell - T cell adhesion and synapse formation. Antigen presenting cells activated CCR2+CD4+ TH17 cells, which appeared to inhibit B cell activation. CD4 T cells were essential for preventing tumor recurrence, indicating that CCR2+ TH17 cells function downstream of senEVs during senescence surveillance. Our findings suggest that senEVs complement the activity of secreted inflammatory mediators by recruiting and activating distinct immune cell subsets, thereby enhancing the efficient clearance of senescent cells. These conclusions may have implications not only for tumor recurrence but also for understanding senescence during de novo carcinogenesis. Consequently, this work could inform the development of novel cancer early detection strategies based on the biology of cellular senescence.

Cancer Biology
Senescent cells develop PDK4-dependent hypercatabolism and form an acidic microenvironment to drive cancer resistance

Xuefeng Dou,Qilai Long,Shuning Liu,Yejun Zou,Da Fu,Xue Chen,Qixia Xu,Changxu Wang,Xiaohui Ren,Guilong Zhang,Qiang Fu,Judith Campisi,Yuzheng Zhao,Yu Sun

DOI: https://doi.org/10.1101/2022.08.29.505761

IF: 11.2

2022-01-01

Cancer Research

Abstract:Cellular senescence is a state of stable growth arrest, usually accompanied by development of the senescence-associated secretory phenotype (SASP). Although senescent cells remain metabolically active, little is known about their metabolic landscape and in vivo pathophysiological implications. Here we show that expression of the pyruvate dehydrogenase (PDH) inhibitory enzyme, pyruvate dehydrogenase kinase 4 (PDK4), is significantly upregulated in human senescent stromal cells. Preferentially expressed upon genotoxicity-induced senescence (GIS), PDK4 is negatively correlated with posttreatment survival of cancer patients. Upon cellular senescence, PDK4 shifts glucose metabolic flux from oxidative phosphorylation to aerobic glycolysis, causing enhanced lactate production and forming an acidic microenvironment. However, distinct from the cancer cell-featured Warburg effect, senescent cells maintain an intensive use of pyruvate through the tricarboxylic acid cycle (TCA), displaying increased respiration and redox activity, indicative of a special form of metabolic reprogramming. Conditioned media from PDK4+ stromal cells change global expression and promote malignancy of recipient cancer cells in vitro and accelerate tumor progression in vivo . Pharmacologically targeting PDK4 restrains the adverse effects of PDK4 in cell-based assays, while promoting tumor regression and extending posttreatment survival in preclinical trials. Together, our study substantiates the hypercatabolic nature of senescent cells, and reveals a metabolic link between senescence-associated acidic microenvironment and age-related pathologies including but not limited to cancer. ### Competing Interest Statement The authors have declared no competing interest.

Supplementary Data from Senescent Stromal Cells Promote Cancer Resistance Through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles

Supplementary Data from Senescent Stromal Cells Promote Cancer Resistance Through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells Against Solid Tumors

Abstract 2969: Senescent Stromal Cells Promote Cancer Resistance Via Sirt1 Loss-Potentiated Biogenesis of Small Extracellular Vesicles

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Supplementary Data from SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence

Targeted Clearance of Senescent Cells via Engineered Extracellular Vesicles Reprograms Tumor Immunosuppressive Microenvironment

Extracellular vesicles within a tumourigenic therapy-induced senescent tumour secretome are able to confer anti-cancer properties

Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression

Abstract P46: Small Extracellular Vesicles from Therapy-induced Senescent TNBC Elicit Paracrine Anti-tumour Effects

Supplementary Data from Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor–Stroma Cross-talk

Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation

Small Extracellular Vesicles Maintain Homeostasis of Senescent Mesenchymal Stem Cells at Least Through Excreting Harmful Lipids

Supplementary Data from Suppression of Anoikis by &lt;i&gt;skp2&lt;/i&gt; Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma

Supplementary Data from Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression

Senescent cell-derived extracellular vesicles inhibit cancer recurrence by coordinating immune surveillance

Senescent cells develop PDK4-dependent hypercatabolism and form an acidic microenvironment to drive cancer resistance

Supplementary Data from Suppression of Anoikis by <i>skp2</i> Amplification and Overexpression Promotes Metastasis of Esophageal Squamous Cell Carcinoma